当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析

宏源药业

(301246)

  

流通市值:22.73亿  总市值:56.80亿
流通股本:1.60亿   总股本:4.00亿

宏源药业(301246)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-0.06亿元,每股收益-0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益433066.81万元,未分配利润160953.10万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产591171.39万元,负债158104.58万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入882,558,988.14433,455,447.871,770,723,711.981,322,234,413.75
营业总成本865,650,935.27416,830,661.031,712,679,177.051,265,739,711.39
其他经营收益
营业利润47,965.9712,256,082.5360,044,626.645,679,264.51
利润总额-803,086.3811,749,473.8759,690,875.4845,366,860.75
净利润-6,408,271.228,823,394.9351,461,755.7336,142,245.31
每股收益
其他综合收益----
综合收益总额-6,408,271.228,823,394.9351,461,755.7336,142,245.31
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,162,525,882.743,101,788,369.333,046,358,976.713,016,003,560.55
非流动资产:
非流动资产合计2,749,188,053.972,771,956,804.012,778,564,582.52,840,655,403.12
资产总计5,911,713,936.715,873,745,173.345,824,923,559.215,856,658,963.67
流动负债:
流动负债合计1,107,515,558.411,184,220,085.761,135,988,909.861,178,469,168.74
非流动负债:
非流动负债合计473,530,267.87331,959,151.69327,788,112.14331,328,211.47
负债合计1,581,045,826.281,516,179,237.451,463,777,0221,509,797,380.21
所有者权益(或股东权益):
归属于母公司股东权益合计4,329,941,050.64,357,099,117.514,360,679,835.594,346,861,583.46
股东权益合计4,330,668,110.434,357,565,935.894,361,146,537.214,346,861,583.46
负债和股东权益合计5,911,713,936.715,873,745,173.345,824,923,559.215,856,658,963.67
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计524,553,808.39224,202,363.11,187,069,499.23772,338,678.87
经营活动现金流出小计694,068,356.89347,790,369.941,202,879,190.15781,377,883.72
经营活动产生的现金流量净额-169,514,548.5-123,588,006.84-15,809,690.92-9,039,204.85
投资活动产生的现金流量:
投资活动现金流入小计2,621,806,486.69534,082,862.634,220,411,057.183,431,165,537.51
投资活动现金流出小计2,963,945,483.6815,633,615.93,806,900,068.282,777,121,703.78
投资活动产生的现金流量净额-342,138,996.91-281,550,753.27413,510,988.9654,043,833.73
筹资活动产生的现金流量:
筹资活动现金流入小计381,042,716.38144,970,430.0351,607,941.7656,061,209.31
筹资活动现金流出小计110,912,950.3525,201,490.05228,507,912.35229,289,250.15
筹资活动产生的现金流量净额270,129,766.03119,768,939.98-176,899,970.59-173,228,040.84
汇率变动对现金及现金等价物的影响495,696.86657,329.264,980,565.433,173,928.92
现金及现金等价物净增加额-241,028,082.52-284,712,490.87225,781,892.82474,950,516.96
期末现金及现金等价物余额341,158,295.5297,473,887.15582,186,378.02831,355,002.16
补充资料:
现金及现金等价物的净增加额-241,028,082.52-225,781,892.82-
TOP↑